Ditchcarbon
  • Contact
  1. Organizations
  2. Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 9 days ago

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Company websiteClaim

Shijiazhuang Yiling Pharmaceutical Co., Ltd., commonly referred to as Yiling Pharmaceutical, is a leading player in the Chinese pharmaceutical industry, headquartered in Shijiazhuang, CN. Established in 1992, the company has made significant strides in the development and production of traditional Chinese medicine and modern pharmaceuticals, focusing on areas such as cardiovascular health, oncology, and respiratory diseases. Yiling Pharmaceutical is renowned for its innovative core products, including the widely acclaimed Yiling Qingfei Paidu Decoction, which exemplifies the integration of traditional practices with contemporary science. With a strong commitment to research and development, the company has achieved notable milestones, positioning itself as a trusted name in both domestic and international markets. Its dedication to quality and efficacy has earned Yiling Pharmaceutical a prominent market position, making it a key contributor to the advancement of healthcare solutions.

DitchCarbon Score

How does Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s score of 22 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.

21%

Let us know if this data was useful to you

Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s reported carbon emissions

In 2023, Shijiazhuang Yiling Pharmaceutical Co., Ltd. reported a carbon intensity of approximately 0.33 tonnes CO2e per million USD in revenue. For 2024, the company aims to achieve a carbon intensity of about 0.008 tonnes CO2e per million USD in revenue. While specific absolute emissions data for Scope 1, 2, and 3 are not disclosed, the company has set ambitious reduction targets for its emissions. Shijiazhuang Yiling Pharmaceutical has committed to reducing its Scope 1 emissions by 50% from 2020 levels by 2025 and aims to achieve net zero for Scope 1 emissions by 2030. Additionally, the company plans to reduce its Scope 2 emissions by 50% from 2020 levels by 2025 and also targets net zero for Scope 2 emissions by 2030. These commitments reflect a proactive approach to climate action and align with industry standards for sustainability. The company's climate initiatives are not cascaded from a parent organisation, indicating that these targets and data are independently established. Shijiazhuang Yiling Pharmaceutical's efforts contribute to the broader pharmaceutical industry's movement towards reducing carbon footprints and enhancing environmental responsibility.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Shijiazhuang Yiling Pharmaceutical Co., Ltd. is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Shijiazhuang Yiling Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Sinopharm Group Co. Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Hengrui Pharma

CN
•
Pharmaceutical Preparation Manufacturing
Updated about 8 hours ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 6 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251016.6
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy